Diagnosis,
Health,
Friction,
Documentation,
Partnership,
Risk,
SAN,
Electronic health record,
Workflow,
EHR,
Mining SAN MATEO, Calif., April 9, 2024 /PRNewswire/ -- Apixio, a leading healthcare data and analytics company, announces a strategic partnership with Vim, a leading point-of-care connection platform, to enhance accurate condition capture during the patient visit and improve patient care. This initiative leverages Apixio's expertise in analyzing structured and unstructured data for enhanced risk adjustment and enables seamless integration within clinical workflows. Apixio's insights include sophisticated analytics and reporting capabilities to monitor performance, promote provider participation, and identify educational opportunities. The collaboration features user-friendly tools that fit effortlessly into provider workflows, fostering greater adoption and engagement.
Key Points:
- Apixio's insights include sophisticated analytics and reporting capabilities to monitor performance, promote provider participation, and identify educational opportunities.
- The healthcare industry is transforming significantly, shifting from retrospective to prospective risk adjustment and/or hybrid models to manage patient care and financial outcomes better.
- Prospective risk adjustment allows healthcare providers and payers to assess patient risk more accurately and timely, improving care management and economic performance.
- However, this shift presents several challenges, including seamlessly integrating insights into EHR systems and ensuring that these insights are delivered efficiently and effectively to clinicians at the point of care.
Certification,
Risk,
HITRUST,
Patient,
SAN,
Prescription,
Population Health Management,
Command,
Collaboration,
Providers,
Health,
Medical device SAN MATEO, Calif., March 14, 2024 /PRNewswire/ -- For over a decade, Apixio has been at the forefront of utilizing both structured and unstructured health data for AI-driven risk adjustment and payment integrity solutions. Today, they announce the launch of Apixio Health Data Nexus™, a connected care platform designed to revolutionize how health data is integrated, analyzed, and utilized to drive positive outcomes across the healthcare ecosystem. Health Data Nexus expands Apixio's solutions offering to address the longstanding challenges of data access and fragmentation in the healthcare industry, offering a comprehensive solution that empowers health plans and providers to unlock the power of health data.
Key Points:
- Today, they announce the launch of Apixio Health Data Nexus™, a connected care platform designed to revolutionize how health data is integrated, analyzed, and utilized to drive positive outcomes across the healthcare ecosystem.
- Health Data Nexus expands Apixio's solutions offering to address the longstanding challenges of data access and fragmentation in the healthcare industry, offering a comprehensive solution that empowers health plans and providers to unlock the power of health data.
- With the introduction of Health Data Nexus, Apixio is expanding its health data infrastructure to payers and providers, enabling them to unlock new opportunities for enhancing efficiency and effectiveness across their operations.
- The session will occur on Tuesday, March 18, at 11:15 AM CT.
To learn more about how Health Data Nexus democratizes data, visit www.apixio.com/healthcare-data-analytics-platform
Retrieved on:
Tuesday, December 5, 2023
Acquisition,
SAN,
Organization,
Creativity,
Albornoz,
AIAA Journal,
Health,
AI,
Health care,
Sales,
Medical device,
Frost SAN MATEO, Calif., Dec. 5, 2023 /PRNewswire/ -- Apixio, a leading healthcare data and analytics company, today announced that its Connected Care Platform earned the Frost & Sullivan 2023 Technology Innovation Leadership Award in the North American Healthcare Payer Analytics Industry. This marks Apixio's second consecutive award from Frost & Sullivan, underscoring its continued excellence and innovation in leveraging technology to enable healthcare's shift toward value-based reimbursement models.
Key Points:
- SAN MATEO, Calif., Dec. 5, 2023 /PRNewswire/ -- Apixio , a leading healthcare data and analytics company, today announced that its Connected Care Platform earned the Frost & Sullivan 2023 Technology Innovation Leadership Award in the North American Healthcare Payer Analytics Industry.
- This marks Apixio's second consecutive award from Frost & Sullivan, underscoring its continued excellence and innovation in leveraging technology to enable healthcare's shift toward value-based reimbursement models.
- "We are honored to once again be recognized by Frost & Sullivan" - Sachin Patel, CEO of Apixio.
- After assessing Apixio and other nominees in the North American Healthcare Payer Analytics Industry, Frost & Sullivan named Apixio the 2023 Technology Innovation Leadership Award recipient.
Managed Care,
Finance,
Health,
Artificial Intelligence,
Banking,
Health Technology,
Professional Services,
Technology,
Artificial intelligence,
Natural language processing,
Private equity,
Intelligence,
Multimedia,
Patient The merger is being supported by New Mountain Capital ("New Mountain”), a leading growth-oriented investment firm with more than $37 billion in assets under management.
Key Points:
- The merger is being supported by New Mountain Capital ("New Mountain”), a leading growth-oriented investment firm with more than $37 billion in assets under management.
- Eir Partners, ClaimLogiq’s first institutional investor, has backed ClaimLogiq since 2021 and will remain a significant minority investor in the combined company.
- Apixio Chief Executive Officer Sachin Patel will become Chief Executive Officer of the combined entity, and ClaimLogiq Chief Executive Officer Tom Magnotta will become President and Chief Operating Officer.
- “With the completion of Apixio’s merger with ClaimLogiq, our combined platform will serve as a compelling offering for the nation’s leading health plans and provider groups,” commented Sachin Patel.
Ropes & Gray,
Artificial intelligence,
EPS,
Centene Corporation,
Private equity,
Intelligence,
PLC,
CNC,
NYSE,
Machine learning,
Bass,
Sale With a patented data science infrastructure, Apixio analyzes structured and unstructured data to develop high-fidelity patient health profiles and support value-based care programs.
Key Points:
- With a patented data science infrastructure, Apixio analyzes structured and unstructured data to develop high-fidelity patient health profiles and support value-based care programs.
- "Apixio has been a trusted business partner since our relationship began in 2015," said Sarah M. London, Chief Executive Officer of Centene.
- We are confident that New Mountain Capital is well positioned to ensure that Apixio continues to support the success of its clients given their sector expertise and long-term focus."
- J.P. Morgan Securities LLC is serving as financial advisor to New Mountain Capital, and Ropes & Gray LLP is serving as its legal counsel.
Retrieved on:
Tuesday, February 21, 2023
Accountable care organization,
Centers for Medicare & Medicaid Services,
Health,
Automation,
Workflow,
MSSP,
Diagnosis,
RISE,
Medicare,
ACO,
Documentation,
Risk,
EHR,
Enabling,
AI,
Health insurance,
Nursing,
Medical device SAN MATEO, Calif., Feb. 21, 2023 /PRNewswire/ -- Apixio, a leading AI platform that powers value-based care, today announced the launch of its new Apicare Post-Visit™ offering, an EHR-integrated intelligent workflow solution for health plans and providers. With the Centers for Medicare & Medicaid Services' recent Medicare Advantage Risk Adjustment Data Validation Final Rule, healthcare organizations need to have complete diagnosis capture and accurate documentation for reimbursement to ensure compliance.
Key Points:
- The new Post-Visit solution completes Apixio's Apicare Prospective Suite™, which also includes Apicare Pre-Visit®, an EHR-integrated solution that optimizes the clinical chart prep process by surfacing insights of suspected conditions from structured and unstructured data, as well as Apicare Point-of-Care™, which pushes risk gaps to clinicians within the EHR workflow for risk capture.
- Concurrent reviews are conducted immediately after the patient encounter prior to claims submission to ensure the diagnosis coding is accurate and supported by the patient encounter documentation.
- This burden contributes to provider-staff abrasion, inaccurate risk capture, and potentially incomplete documentation of patient conditions to support value-based care workflows.
- Apixio's Post-Visit solution solves these problems with an AI-driven workflow that mines through encounter data immediately following a patient visit to surface ICDs.
Retrieved on:
Tuesday, December 8, 2020
ST. LOUIS, Dec. 8, 2020 /PRNewswire/ --Centene Corporation (NYSE: CNC) today announced that it has completed its acquisition of Apixio, a healthcare analytics company offering Artificial Intelligence (AI) technology solutions.
Key Points:
- ST. LOUIS, Dec. 8, 2020 /PRNewswire/ --Centene Corporation (NYSE: CNC) today announced that it has completed its acquisition of Apixio, a healthcare analytics company offering Artificial Intelligence (AI) technology solutions.
- With this transaction, Centene will continue to digitize the administration of healthcare and accelerate innovation and modernization across the enterprise.
- "We are pleased to have completed our acquisition of Apixio, further solidifying our position as a technology company focused on healthcare," said Michael F. Neidorff, Chairman, President and Chief Executive Officer for Centene.
- "I would like to officially welcome the Apixio team to the Centene family and look forward to working together to leverage comprehensive data to help improve the lives of our members."
"Organizations investing in value-based care want the smartest technology available, and Apixio's platform is becoming more intelligent every day," said Tom McNamara, Chief Revenue Officer at Apixio.
Key Points:
- "Organizations investing in value-based care want the smartest technology available, and Apixio's platform is becoming more intelligent every day," said Tom McNamara, Chief Revenue Officer at Apixio.
- We're poised for another year of rapid growth, and we're putting the right people in place to ensure our ongoing success."
- Apixio also announced the addition of two respected industry experts from leading healthcare organizations to its team: Jennifer Pereur, Vice President of Solutions, and Terry Ward, Senior Vice President of Solutions.
- She brings 20 years of industry expertise in creating and managing government programs for risk-bearing provider groups, and inhealthcare data analytics.
Retrieved on:
Wednesday, February 6, 2019
SAN MATEO, Calif., Feb. 6, 2019 /PRNewswire/ -- Apixio Inc. , a leading healthcare AI analytics company, today announced the promotion of two sales executives to senior positions.
Key Points:
- SAN MATEO, Calif., Feb. 6, 2019 /PRNewswire/ -- Apixio Inc. , a leading healthcare AI analytics company, today announced the promotion of two sales executives to senior positions.
- The company promoted Lou Steinberg to Senior Vice President, Payer Market Sales and Mark Hellewell to Vice President, Provider Market Sales.
- Steinberg and Hellewell will assume key leadership positions on the sales team as the company expands its market leadership position with payers and providers.
- Mark Hellewell,a sales veteran with fifteen years of healthcare and technology experience,previously served as Vice President of Sales, Western Region, and has been with Apixio for five years.
